← back to search

Ganqiang Liu

Sun Yat-sen University · CN
Area of research
Neurology · Molecular Biology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Nuclear Receptors and Signaling, Lysosomal Storage Disorders Research, and RNA Research and Splicing.
h-index
20
citations
2,096
works
56
NIH funding
primary concept
email

Recent publications

A machine learning-derived speech index as a biomarker for Huntington's disease severity
Journal of Neurology 2026cited by 0position: lastdoi
<scp><i>GBA</i></scp> and <scp><i>APOE</i></scp> Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
Movement Disorders 2022cited by 116position: middledoi
Mitochondrial haplogroups and cognitive progression in Parkinson’s disease
Brain 2022cited by 23position: firstdoi
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
Nature Genetics 2021cited by 137position: firstdoi
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
npj Parkinson s Disease 2021cited by 55position: middledoi
Differences in the Presentation and Progression of Parkinson's Disease by Sex
Movement Disorders 2020cited by 100position: middledoi
Impact of<i>GBA1</i>variants on long-term clinical progression and mortality in incident Parkinson’s disease
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 93position: middledoi
β-Glucocerebrosidase activity in <i>GBA</i> -linked Parkinson disease
Neurology 2020cited by 47position: middledoi
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
Movement Disorders 2019cited by 189position: middledoi
DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood
Epigenetics 2019cited by 90position: middledoi
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Nature Neuroscience 2018cited by 106position: middledoi
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Annals of Neurology 2016cited by 276position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Clemens R. Scherzer · Yale University7 papers (2016–2022)Sophie Winder‐Rhodes · University of Cambridge3 papers (2016–2022)Caroline H. Williams‐Gray · University of Cambridge3 papers (2016–2022)Joseph J. Locascio · Harvard University3 papers (2018–2021)Marta Camacho · Universitat de Barcelona2 papers (2020–2022)Peter Heutink · University of Tübingen2 papers (2016–2018)Ming Sum Ruby Chiang · Sanofi (France)2 papers (2020–2021)Roger A. Barker · Research Network (United States)2 papers (2016–2020)Zhixiang Liao · Harvard University Press2 papers (2018–2020)Young Eun Huh · National University College2 papers (2020–2021)S. Pablo Sardi · Sanofi (United States)2 papers (2020–2021)Idil Tuncali · Brigham and Women's Hospital2 papers (2020–2021) · 1 papers (2018–2018)Ole‐Bjørn Tysnes · Haukeland University Hospital1 papers (2022–2022)Rachael Lawson · University of Queensland1 papers (2022–2022)Kristen Jepsen · University of California San Diego1 papers (2019–2019)Stephen N. Gomperts · Harvard University1 papers (2020–2020) · 1 papers (2016–2016) · 1 papers (2016–2016)Michael A. Schwarzschild · Harvard University1 papers (2020–2020)